Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Mineral Resources International Announces Termination of Exclusive Supply Agreement with Trace Minerals Research
Company announces that its exclusive supply agreement for the U.S. health food store market with distributor Trace Minerals Research (TMR) has ended.
- Mineral Resources International Announces Termination of Exclusive Supply Agreement with Trace Minerals Research
Company announces that its exclusive supply agreement for the U.S. health food store market with distributor Trace Minerals Research (TMR) has ended.
- Martek Announces Third Quarter Financial Results
Company reports revenues of $70.4 million were achieved, compared to $39.5 million for the third quarter of fiscal 05 , with net income of $5.3 million, or $0.16 per diluted share, compared to net loss of $100,000, or $0.00 per diluted share, for the 3rd Qtr 05.
- Martek Announces Third Quarter Financial Results
Company reports revenues of $70.4 million were achieved, compared to $39.5 million for the third quarter of fiscal 05 , with net income of $5.3 million, or $0.16 per diluted share, compared to net loss of $100,000, or $0.00 per diluted share, for the 3rd Qtr 05.
- Jamieson Laboratories Centralizes Manufacturing with Closure of Vancouver Facility
Company is closing Vancouver plant in order to centralize manufacturing operations at state-of-the-art facilities at
headquarters in Windsor, Ontario.
- Jamieson Laboratories Centralizes Manufacturing with Closure of Vancouver Facility
Company is closing Vancouver plant in order to centralize manufacturing operations at state-of-the-art facilities at
headquarters in Windsor, Ontario.
- Jamieson Laboratories Centralizes Manufacturing with Closure of Vancouver Facility
Company is closing Vancouver plant in order to centralize manufacturing operations at state-of-the-art facilities at
headquarters in Windsor, Ontario.
- Trace Minerals Research Partners with Salt Lake Minerals
Company has negotiated an exclusive agreement with Salt Lake Minerals, a mineral and trace mineral extraction facility located on Utah's Great Salt Lake.
- Trace Minerals Research Partners with Salt Lake Minerals
Company has negotiated an exclusive agreement with Salt Lake Minerals, a mineral and trace mineral extraction facility located on Utah's Great Salt Lake.
- SunOpta Quadruples Acai Business
Company has provided an update on its North American Acai business, expecting to quadruple its sales of Acai in North America to approximately $4.0 million over the next 12 months.
- SunOpta Quadruples Acai Business
Company has provided an update on its North American Acai business, expecting to quadruple its sales of Acai in North America to approximately $4.0 million over the next 12 months.
- SunOpta Quadruples Acai Business
Company has provided an update on its North American Acai business, expecting to quadruple its sales of Acai in North America to approximately $4.0 million over the next 12 months.
- Chrysantis Granted Zeaxanthin Esters Patent
The US Patent Office has issued Chrysantis patent number US 7,081,478 for its development of zeaxanthin esters.
- Chrysantis Granted Zeaxanthin Esters Patent
The US Patent Office has issued Chrysantis patent number US 7,081,478 for its development of zeaxanthin esters.
- Chrysantis Granted Zeaxanthin Esters Patent
The US Patent Office has issued Chrysantis patent number US 7,081,478 for its development of zeaxanthin esters.
- EuroPharma Signs Exclusive Agreement With New Chapter to Distribute Vectomega® Into Health Food/Natural Product Retail Channel
EuroPharma and New Chapter have signed an agreement appointing New Chapter as the exclusive distributor of Vectomega® for the health food/natural product retail channel.
- EuroPharma Signs Exclusive Agreement With New Chapter to Distribute Vectomega® Into Health Food/Natural Product Retail Channel
EuroPharma and New Chapter have signed an agreement appointing New Chapter as the exclusive distributor of Vectomega® for the health food/natural product retail channel.
- EuroPharma Signs Exclusive Agreement With New Chapter to Distribute Vectomega® Into Health Food/Natural Product Retail Channel
EuroPharma and New Chapter have signed an agreement appointing New Chapter as the exclusive distributor of Vectomega® for the health food/natural product retail channel.
- EuroPharma Signs Exclusive Agreement With New Chapter to Distribute Vectomega® Into Health Food/Natural Product Retail Channel
EuroPharma and New Chapter have signed an agreement appointing New Chapter as the exclusive distributor of Vectomega® for the health food/natural product retail channel.
- EuroPharma Signs Exclusive Agreement With New Chapter to Distribute Vectomega® Into Health Food/Natural Product Retail Channel
EuroPharma and New Chapter have signed an agreement appointing New Chapter as the exclusive distributor of Vectomega® for the health food/natural product retail channel.
- Atrium acquires Douglas Laboratories Canada
Company announces the acquisition, effective today, of the assets of London, Ontario based Douglas Laboratories Canada, with current annual revenues of approximately $5 million.
- Atrium acquires Douglas Laboratories Canada
Company announces the acquisition, effective today, of the assets of London, Ontario based Douglas Laboratories Canada, with current annual revenues of approximately $5 million.
- Atrium acquires Douglas Laboratories Canada
Company announces the acquisition, effective today, of the assets of London, Ontario based Douglas Laboratories Canada, with current annual revenues of approximately $5 million.
- Nutrition 21 Reports Fiscal Fourth-Quarter and Full-Year 2006 Results
Company reports Q4 revenues of $2.5 million, compared to $1.9 million for the comparable period a year ago, with a net loss of $3.7 million or $(0.09) loss per diluted share compared to a $3.7 million or $(0.10) loss per diluted share in the 2005 period.
- Nutrition 21 Reports Fiscal Fourth-Quarter and Full-Year 2006 Results
Company reports Q4 revenues of $2.5 million, compared to $1.9 million for the comparable period a year ago, with a net loss of $3.7 million or $(0.09) loss per diluted share compared to a $3.7 million or $(0.10) loss per diluted share in the 2005 period.
- SoyLink(R) Receives Breakthrough Patent on Soy Powder Processing
Company has been issued a patent through the United States Patent and Trademark Office (US 7,097,871 B2 entitled "Deflavored Vegetable Powders, Methods of Making Them, and Systems for Vegetable Milling") that covers proprietary technology used to produce SoyLink's line of highly functional soybean protein powders
- SoyLink(R) Receives Breakthrough Patent on Soy Powder Processing
Company has been issued a patent through the United States Patent and Trademark Office (US 7,097,871 B2 entitled "Deflavored Vegetable Powders, Methods of Making Them, and Systems for Vegetable Milling") that covers proprietary technology used to produce SoyLink's line of highly functional soybean protein powders
- SoyLink(R) Receives Breakthrough Patent on Soy Powder Processing
Company has been issued a patent through the United States Patent and Trademark Office (US 7,097,871 B2 entitled "Deflavored Vegetable Powders, Methods of Making Them, and Systems for Vegetable Milling") that covers proprietary technology used to produce SoyLink's line of highly functional soybean protein powders
- Carrington and Swanson Health Sign Supply and Licensing Agreements for Manapol(R) Powder
Carrington Laboratories, Inc. has announced today it has entered into a two-year, non- exclusive supply agreement for Manapol(R) powder and a licensing agreement for the Manapol(R) trademark and logo with Swanson Health Products(TM).
- Carrington and Swanson Health Sign Supply and Licensing Agreements for Manapol(R) Powder
Carrington Laboratories, Inc. has announced today it has entered into a two-year, non- exclusive supply agreement for Manapol(R) powder and a licensing agreement for the Manapol(R) trademark and logo with Swanson Health Products(TM).
- Natural Alternatives International, Inc. Announces Fourth Quarter Results
Company reports net income of $1.2 million or $0.16 per diluted share on revenues of $34.2 million for Q4, compared to $285,000 or $0.04 per diluted share on revenues of $24.7 million for the comparable quarter last year.
- Natural Alternatives International, Inc. Announces Fourth Quarter Results
Company reports net income of $1.2 million or $0.16 per diluted share on revenues of $34.2 million for Q4, compared to $285,000 or $0.04 per diluted share on revenues of $24.7 million for the comparable quarter last year.
- Planet Organic Acquires Second Store in Edmonton
Company will acquire The Big Fresh, a 5,000 square-foot natural food market situated in a prime location at Jasper Avenue and 121 Street in Edmonton.
- Planet Organic Acquires Second Store in Edmonton
Company will acquire The Big Fresh, a 5,000 square-foot natural food market situated in a prime location at Jasper Avenue and 121 Street in Edmonton.
- Planet Organic Acquires Second Store in Edmonton
Company will acquire The Big Fresh, a 5,000 square-foot natural food market situated in a prime location at Jasper Avenue and 121 Street in Edmonton.
- Kirin Group and Yakult Group to jointly establish Kirin Yakult NextStage as part of alliance
Kirin Brewery Company, Limited and Yakult Honsha Co. Ltd. have announced that they had jointly established Kirin Yakult NextStage Company, Limited to develop next-generation health foods and functional foods business. The company will begin operations on October 1 and on October 2, will launch nationwide sales of BBcube, a product that supports healthy intestinal bacteria balance.
- Kirin Group and Yakult Group to jointly establish Kirin Yakult NextStage as part of alliance
Kirin Brewery Company, Limited and Yakult Honsha Co. Ltd. have announced that they had jointly established Kirin Yakult NextStage Company, Limited to develop next-generation health foods and functional foods business. The company will begin operations on October 1 and on October 2, will launch nationwide sales of BBcube, a product that supports healthy intestinal bacteria balance.
- Kirin Group and Yakult Group to jointly establish Kirin Yakult NextStage as part of alliance
Kirin Brewery Company, Limited and Yakult Honsha Co. Ltd. have announced that they had jointly established Kirin Yakult NextStage Company, Limited to develop next-generation health foods and functional foods business. The company will begin operations on October 1 and on October 2, will launch nationwide sales of BBcube, a product that supports healthy intestinal bacteria balance.
- Kirin Group and Yakult Group to jointly establish Kirin Yakult NextStage as part of alliance
Kirin Brewery Company, Limited and Yakult Honsha Co. Ltd. have announced that they had jointly established Kirin Yakult NextStage Company, Limited to develop next-generation health foods and functional foods business. The company will begin operations on October 1 and on October 2, will launch nationwide sales of BBcube, a product that supports healthy intestinal bacteria balance.
- Kirin Group and Yakult Group to jointly establish Kirin Yakult NextStage as part of alliance
Kirin Brewery Company, Limited and Yakult Honsha Co. Ltd. have announced that they had jointly established Kirin Yakult NextStage Company, Limited to develop next-generation health foods and functional foods business. The company will begin operations on October 1 and on October 2, will launch nationwide sales of BBcube, a product that supports healthy intestinal bacteria balance.
- Kirin Group and Yakult Group to jointly establish Kirin Yakult NextStage as part of alliance
Kirin Brewery Company, Limited and Yakult Honsha Co. Ltd. have announced that they had jointly established Kirin Yakult NextStage Company, Limited to develop next-generation health foods and functional foods business. The company will begin operations on October 1 and on October 2, will launch nationwide sales of BBcube, a product that supports healthy intestinal bacteria balance.
- Nu Skin Enterprises to Open Operations in Costa Rica
Company announces the opening of Costa Rica as the company's 44th global market, where both Nu Skin(R) personal care and Pharmanex(R) nutritional products will be launched.
- Nu Skin Enterprises to Open Operations in Costa Rica
Company announces the opening of Costa Rica as the company's 44th global market, where both Nu Skin(R) personal care and Pharmanex(R) nutritional products will be launched.
- Origin BioMed Acquires MedPress and NeuroHelp
BioMed Inc. announced today that it has
acquired the book publisher MedPress(TM) (www.medpress.com) as well as the supplement company NeuroHelp(TM) (www.neurohelp.com).
- Origin BioMed Acquires MedPress and NeuroHelp
BioMed Inc. announced today that it has
acquired the book publisher MedPress(TM) (www.medpress.com) as well as the supplement company NeuroHelp(TM) (www.neurohelp.com).
- Origin BioMed Acquires MedPress and NeuroHelp
BioMed Inc. announced today that it has
acquired the book publisher MedPress(TM) (www.medpress.com) as well as the supplement company NeuroHelp(TM) (www.neurohelp.com).
- Forward Foods, LLC Acquires Detour Protein Bars
Forward Foods, LLC and NEXT Proteins, Inc. have announced the sale of NEXT's protein bar business to Forward Foods.
- Forward Foods, LLC Acquires Detour Protein Bars
Forward Foods, LLC and NEXT Proteins, Inc. have announced the sale of NEXT's protein bar business to Forward Foods.
- Forward Foods, LLC Acquires Detour Protein Bars
Forward Foods, LLC and NEXT Proteins, Inc. have announced the sale of NEXT's protein bar business to Forward Foods.
- Forward Foods, LLC Acquires Detour Protein Bars
Forward Foods, LLC and NEXT Proteins, Inc. have announced the sale of NEXT's protein bar business to Forward Foods.
- David D. Belaga Named Senior Vice President – Worldwide Marketing and Sales of Sciona, Inc.
Company announces that David D. Belaga, previously Senior Vice President of Marketing at Amerifit Nutrition, Inc., has been named Senior Vice President – Worldwide Marketing and Sales.
- David D. Belaga Named Senior Vice President – Worldwide Marketing and Sales of Sciona, Inc.
Company announces that David D. Belaga, previously Senior Vice President of Marketing at Amerifit Nutrition, Inc., has been named Senior Vice President – Worldwide Marketing and Sales.
- David D. Belaga Named Senior Vice President – Worldwide Marketing and Sales of Sciona, Inc.
Company announces that David D. Belaga, previously Senior Vice President of Marketing at Amerifit Nutrition, Inc., has been named Senior Vice President – Worldwide Marketing and Sales.
- David D. Belaga Named Senior Vice President – Worldwide Marketing and Sales of Sciona, Inc.
Company announces that David D. Belaga, previously Senior Vice President of Marketing at Amerifit Nutrition, Inc., has been named Senior Vice President – Worldwide Marketing and Sales.
- Swiss Medica Is Ranked #3 In Profit Magazine’s Hot 50 Canadian Emerging Growth Companies
Company has been ranked # 3 in the top 50 emerging growth companies in Canada according to the 7th annual PROFIT HOT 50 ranking.
- Swiss Medica Is Ranked #3 In Profit Magazine’s Hot 50 Canadian Emerging Growth Companies
Company has been ranked # 3 in the top 50 emerging growth companies in Canada according to the 7th annual PROFIT HOT 50 ranking.
- Swiss Medica Is Ranked #3 In Profit Magazine’s Hot 50 Canadian Emerging Growth Companies
Company has been ranked # 3 in the top 50 emerging growth companies in Canada according to the 7th annual PROFIT HOT 50 ranking.
- Frutarom Signs Agreement for Exclusive Global License to Produce and Market a Unique Plant Extract to Reduce and Stabilize Glucose Levels in Blood of Diabetes and Pre-Diabetes Patients
Company has signed an exclusive global licensing agreement with D-Herb, of the NGT technological incubator in Nazareth, Israel, to produce and globally market a unique herbal extract, for the reduction and stabilization of glucose levels in the blood of diabetes and pre-diabetes patients.
- Frutarom Signs Agreement for Exclusive Global License to Produce and Market a Unique Plant Extract to Reduce and Stabilize Glucose Levels in Blood of Diabetes and Pre-Diabetes Patients
Company has signed an exclusive global licensing agreement with D-Herb, of the NGT technological incubator in Nazareth, Israel, to produce and globally market a unique herbal extract, for the reduction and stabilization of glucose levels in the blood of diabetes and pre-diabetes patients.
- Frutarom Signs Agreement for Exclusive Global License to Produce and Market a Unique Plant Extract to Reduce and Stabilize Glucose Levels in Blood of Diabetes and Pre-Diabetes Patients
Company has signed an exclusive global licensing agreement with D-Herb, of the NGT technological incubator in Nazareth, Israel, to produce and globally market a unique herbal extract, for the reduction and stabilization of glucose levels in the blood of diabetes and pre-diabetes patients.
- National Bioscience Corporation Attains Eexclusive Rights To Xanthigen Patent-Pending Weight Loss Ingredient From Deep-Sea Water Cultivated Marine Vegetables
National Bioscience Corporation (NBC), Chester, NY announced today that they have attained exclusive worldwide rights to an exciting new patent-pending product Xanthigen(TM) (proprietary extracts of deep-sea water cultivated marine vegetable extracts standardized to fucoxanthin, neoxanthin, violaxanthin, and marine vegetable ω-3 oils).
- National Bioscience Corporation Attains Eexclusive Rights To Xanthigen Patent-Pending Weight Loss Ingredient From Deep-Sea Water Cultivated Marine Vegetables
National Bioscience Corporation (NBC), Chester, NY announced today that they have attained exclusive worldwide rights to an exciting new patent-pending product Xanthigen(TM) (proprietary extracts of deep-sea water cultivated marine vegetable extracts standardized to fucoxanthin, neoxanthin, violaxanthin, and marine vegetable ω-3 oils).
- National Bioscience Corporation Attains Eexclusive Rights To Xanthigen Patent-Pending Weight Loss Ingredient From Deep-Sea Water Cultivated Marine Vegetables
National Bioscience Corporation (NBC), Chester, NY announced today that they have attained exclusive worldwide rights to an exciting new patent-pending product Xanthigen(TM) (proprietary extracts of deep-sea water cultivated marine vegetable extracts standardized to fucoxanthin, neoxanthin, violaxanthin, and marine vegetable ω-3 oils).
- Trace Minerals Research Files Lawsuit Against Mineral Resources International
Trace Minerals Research has announced that it has taken legal action against Mineral Resources International for trademark infringement and misuse of the company's intellectual property.
- Trace Minerals Research Files Lawsuit Against Mineral Resources International
Trace Minerals Research has announced that it has taken legal action against Mineral Resources International for trademark infringement and misuse of the company's intellectual property.
- New Patent-pending Indications for Natural Vitamin K2 Announced by PL Thomas in Strategic Alliance with Natto Pharma and VitaK BV
Company has announced new patent-pending indications for its Natural Vitamin K2 marketed under the trademark MenaQ7(TM) through an alliance with Natto Pharma, Norway and VitaK BV. Natto Pharma, as part of the Strategic Alliance, has acquired three US patents pending from VitaK, which is closely associated with the Cardiovascular Research Institute, University of Maastricht, The Netherlands.
- New Patent-pending Indications for Natural Vitamin K2 Announced by PL Thomas in Strategic Alliance with Natto Pharma and VitaK BV
Company has announced new patent-pending indications for its Natural Vitamin K2 marketed under the trademark MenaQ7(TM) through an alliance with Natto Pharma, Norway and VitaK BV. Natto Pharma, as part of the Strategic Alliance, has acquired three US patents pending from VitaK, which is closely associated with the Cardiovascular Research Institute, University of Maastricht, The Netherlands.
- My Family Farm Adds New Ingredient To ‘Bake The World a Better Place’ By Offering 'Healthy Products For Healthy Families’
Company announces that net profits generated from the sale of its products will benefit its new charitable partner – Prevent Child Abuse America.
- My Family Farm Adds New Ingredient To ‘Bake The World a Better Place’ By Offering 'Healthy Products For Healthy Families’
Company announces that net profits generated from the sale of its products will benefit its new charitable partner – Prevent Child Abuse America.
- Planet Organic Announces New Stores in Alberta and Ontario
Company has commenced construction of a new 10,000 square foot organic supermarket in Port Credit, Ontario, and is set to open their store in north Calgary, Alberta, the second location in that city.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
TAMPA, Fla. & MATAWAN, N.J., Sep 13, 2006 (BUSINESS WIRE) -- UTEK Corporation (UTK) (LSE-AIM:UTK), a specialty finance company focused on technology transfer, and MM2 Group, Inc. (MMGP) , a financial consulting group focused on nutraceuticals, are pleased to announce that they have signed a strategic alliance agreement.
Mark Meller, Chief Executive Officer of MM2 Group, Inc. said, "We are enthusiastic about forming a strategic alliance with UTEK Corporation which we believe will enable us to identify synergistic technology acquisition opportunities. We are especially excited given UTEK's expertise in nutraceuticals and supplements, which fits well with our current business plans."
"UTEK looks forward to working with MM2 Group, Inc. to identify and potentially transfer proprietary technologies that will be synergistic with its core business," said Doug Schaedler, Chief Operating Officer of UTEK Corporation. Through its strategic alliance agreements, UTEK assists companies in enhancing their new product pipeline with the acquisition of proprietary intellectual capital from universities and laboratory research centers. Strategic alliance agreements are generally cancelable by either party with thirty days advance written notice.
About MM2 Group, Inc. MM2 Group, Inc. is a financial consulting group, providing both publicly-traded and private companies with short-term, mid-term, and long-term capital. MM2 Group, Inc. is also focused on an aggressive acquisition strategy and is supported by our solid working relationships with some of the largest and most respected investment funds, venture capital firms, and hedge funds in the world. The Company has recently announced its intention to acquire Genotec Nutritionals, Inc., a leading nutraceutical manufacturing and distribution company. For more information about MM2 Group, Inc., please visit its website at http://mm2group.net.
About UTEK Corporation UTEK(R) is a specialty finance company focused on technology transfer. UTEK's services enable companies to acquire innovative technologies from universities and research laboratories worldwide. UTEK facilitates the identification and acquisition of external technologies for clients in exchange for their equity securities. This unique process is called U2B(R). In addition, UTEK offers companies the tools to search, analyze and manage university intellectual properties. UTEK is a business development company with operations in the United States, United Kingdom and Israel. For more information about UTEK, please visit its website at http://www.utekcorp.com .
Forward-Looking Statements Certain matters discussed in this press release are "forward-looking statements." These forward-looking statements can generally be identified as such because the context of the statement will include words, such as UTEK or MM2 Group, Inc. "expects," "should," "believes," "anticipates" or words of similar import. Similarly, statements that describe UTEK's or MM2 Group, Inc.'s future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties, including the financial performance of UTEK or MM2 Group, Inc., as appropriate, and the valuation of UTEK's investment portfolio, which could cause actual results to differ materially from those currently anticipated. Although UTEK and MM2 Group, Inc. believe the expectations reflected in any forward-looking statements are based on reasonable assumptions, they cannot give any assurance that their expectations will be attained. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating any forward-looking statements. Certain factors could cause results and conditions to differ materially from those projected in these forward-looking statements, and some of these factors are discussed below. These factors are not exhaustive. New factors, risks and uncertainties may emerge from time to time that may affect the forward-looking statements made herein. These forward-looking statements are only made as of the date of this press release and both UTEK and MM2 Group, Inc. do not undertake any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
UTEK's operating results could fluctuate significantly due to a number of factors. These factors include the small number of transactions that are completed each quarter, the value of individual transactions, the timing of the recognition and the magnitude of unrealized gains and losses, UTEK's dependence on the performance of companies in its portfolio, the possibility that advances in technology could render the technologies it has transferred obsolete, the loss of technology licenses by companies in its portfolio, the degree to which it encounters competition in its markets, the volatility of the stock market and the volatility of the valuations of the companies it has invested in as it relates to its realized and unrealized gains and losses, the concentration of investments in a small number of companies, as well as other general economic conditions. As a result of these and other factors, current results may not be indicative of UTEK's future performance. For more information on UTEK and for a more complete discussion of the risks pertaining to an investment in UTEK, please refer to UTEK's filings with the Securities and Exchange Commission. |